Organisation paid for research Program year 2025 Source: CMS Open Payments

Wesley Optometric Consulting LLC

Neither a doctor nor a teaching hospital

Research payments

$794,170

767 payments

Through program year 2025, Wesley Optometric Consulting LLC is reported as receiving $794,170 in research payments, across 767 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$174,741	77
2024	Research	$156,218	101
2023	Research	$75,355	107
2022	Research	$234,634	268
2021	Research	$71,965	79
2020	Research	$81,256	135

Breakdown

Who paid Research payments · program years 2020–2025

Alcon Research LLC $644,625 752 payments
Oyster Point Pharma, Inc. $149,545 15 payments

Studies the money was for Research payments · program years 2020–2025

A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis $149,545 15 payments
Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses $147,019 189 payments
Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses $87,880 75 payments
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact lenses $70,033 74 payments
Clinical Evaluation of Soft Contact Lenses $57,711 62 payments
Clinical Comparison of Two Daily Disposable Contact Lenses $46,340 62 payments
Clinical Performance of Two Daily Disposable Soft Contact Lenses $45,630 60 payments
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses $44,554 52 payments
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses $35,824 26 payments
Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1 $23,426 43 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.